查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392087

患者來源異種移植模型市場：依模型類型、植入方法、腫瘤類型、應用、最終用戶、地區

Patient Derived Xenograft Model Market, By Model Type, By Implantation Method, By Tumor Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

患者來源異種移植模型市場規模預計將從 2023 年的 1.054 億美元增至 2030 年的 3.46 億美元，預測期內複合年成長率為 18.5%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 1.054億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 18.50% 2030年市場規模預測 3.46億美元
圖 1. 2023 年患者來源異種移植模型的全球市場佔有率(%)（依地區）
病人衍生異種移植模型市場-IMG1

患者來源異種移植（患者來源異種移植）模型是腫瘤學研究中使用的尖端臨床前研究工具。這是一種腫瘤模型，透過將癌症患者的腫瘤組織移植到小鼠或其他免疫力缺乏的動物體內，更真實地再現人類腫瘤的行為。患者來源異種移植模型在藥物研發和藥物開發中廣受歡迎，因為它們可以模擬患者特異性的腫瘤特徵和對治療的反應。

此理論資訊部落格旨在概述患者來源異種移植模型市場，包括市場動態和關鍵特徵。它將幫助相關人員了解該市場當前和未來的趨勢並做出資訊的決策。

市場動態：

患者來源異種移植模型市場預計在未來幾年將顯著成長。有幾個因素正在推動這一市場的擴張。首先，全球癌症發生率不斷上升，對有效的治療方案產生了強烈需求。患者來源異種移植模型是研究腫瘤生物學、評估藥物療效和確定個體化治療策略的寶貴工具。

此外，對精準醫療和個體化治療的日益關注也促進了患者來源異種移植模型市場的成長。這些模型提供了一個平台，用於測試新的候選藥物並評估特定患者群體的潛在反應。此外，製藥和生技公司擴大採用源自患者的異種移植模型進行臨床前研究，也推動了市場的成長。

然而，患者來源異種移植模型市場也面臨一些課題。主要的阻礙因素之一是創建和維護患者來源異種移植模型的高成本。這些模型的複雜性，包括遺傳異質性以及對專門基礎設施和專業知識的需求，增加了整體成本。

也就是說，市場上存在一些對主要企業有吸引力的機會。基因組編輯工具和人源化小鼠模型等技術進步將提高源自患者的異種移植模型的效用和可移植性。此外，製藥公司、學術研究機構和受託研究機構之間的合作可能會進一步加速患者來源異種移植模型的採用和可用性。

本研究的主要特點

這項關於患者衍生異種移植模型市場的研究涵蓋了各種重要特徵，並提供了對市場格局的全面見解。

  • 市場規模與成長：提供全球患者源性異種異質骨移植模型市場的詳細分析，包括市場規模（以百萬美元為單位）和2023年至2030年預測期間的複合年成長率（以2022年為基準年） 。
  • 商機：透過發現不同區隔市場中的潛在收入機會並提出一系列有吸引力的投資提案，幫助相關人員識別商機。
  • 市場促進因素、抑制因素和機會：它提供了有關市場促進因素、市場抑制因素和市場機會的重要見解，並揭示了影響市場成長的因素。它還重點介紹了新產品的發布和核准、市場趨勢、區域前景以及主要企業採取的競爭策略。
  • 公司概況：根據公司亮點、產品系列、主要成就、財務實績和策略等參數對全球患者源性異種移植模型市場的主要企業進行了介紹。本研究涵蓋的公司名單包括THE JACKSON LABORATORY、Champions Oncology, Inc、Charles River Laboratories、Crown Bioscience、Hera Biolabs、Horizo​​​​n Discovery Ltd.、Oncodesign、Pharmast Services、上海力德生物科技、Aragen Life Sciences Ltd. 、Creative Animodel 、Urosphere、Applied StemCell、藥明康德等。
  • 決策見解 本報告為行銷人員和負責人提供了寶貴的資訊，幫助他們就產品發布、產品類型升級、經營團隊擴張和行銷策略做出明智的決策。
  • 相關人員利益：全球患者來源異種移植模型市場報告針對產業內的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。透過用於市場分析的各種策略矩陣促進決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 癌症研究的增加
    • 抑制因素
  • 患者來源異種移植模型的局限性
    • 機會
  • 在免疫治療測試中的應用
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第 4 章 患者來源異種移植模型市場 -冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第 5 章 2018-2030 年患者來源異種移植模型市場（依模型類型）

  • 介紹
  • 腫瘤外植體模型
  • 細胞株衍生模型
  • 患者來源的類器官
  • 基因改造模型
  • 其他（原代細胞衍生模型、細胞加工模型等）

第6章 2018-2030 年患者來源異種移植模型市場（依移植方法）

  • 介紹
  • 皮下植入
  • 整形外科移植
  • 其他

第 7 章 2018-2030 年患者來源異種移植模型市場（依腫瘤類型）

  • 介紹
  • 胃腸道腫瘤模型
  • 婦科腫瘤模型
  • 呼吸道腫瘤模型
  • 其他腫瘤模型

第 8 章 2018-2030 年病患衍生異種移植模型市場，依最終使用者分類

  • 介紹
  • 製藥和生物技術公司
  • 受託研究機構
  • 學術/研究機構
  • 其他

第 9 章 2018-2030 年病患來源異種移植模型市場（依地區）

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭形勢

  • THE JACKSON LABORATORY
  • Champions Oncology, Inc
  • Charles River Laboratories
  • Crown Bioscience
  • Hera Biolabs
  • Horizon Discovery Group
  • Oncodesign
  • Pharmatest Services
  • Shanghai LIDE Biotech
  • Aragen Life Sciences Ltd.
  • Creative Animodel
  • Urosphere
  • Applied StemCell
  • WuXi AppTec

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6506

The Patient Derived Xenograft Model Market size is expected to reach US$ 346 million by 2030, from US$ 105.4 million in 2023, at a CAGR of 18.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 105.4 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 18.50% 2030 Value Projection: US$ 346 Mn
Figure 1. Global Patient Derived Xenograft Model Market Share (%), by Region, 2023
Patient Derived Xenograft Model Market - IMG1

Patient Derived Xenograft (PDX) Model is a cutting-edge preclinical research tool used in oncology research. It is a type of tumor model where tumor tissues from cancer patients are implanted into mice or other immunodeficient animals to create a more realistic representation of the tumor's behavior in humans. PDX models have gained significant popularity in drug discovery and development due to their ability to mimic patient-specific tumor characteristics and response to treatments.

This theoretical informative blog aims to provide an overview of the Patient Derived Xenograft Model market, including its market dynamics and key features. It will assist stakeholders in understanding the current and future trends in this market and making informed decisions.

Market Dynamics:

The Patient Derived Xenograft Model market is expected to witness substantial growth in the coming years. Several factors are driving this market expansion. Firstly, the increasing prevalence of cancer globally is creating a strong demand for effective treatment options. PDX models offer a valuable tool for studying tumor biology, evaluating drug efficacy, and identifying personalized treatment strategies.

Moreover, the rising focus on precision medicine and personalized therapies further contributes to the growth of the PDX model market. These models provide a platform for testing novel drug candidates and evaluating their potential response in specific patient cohorts. Additionally, the growing adoption of PDX models by pharmaceutical and biotechnology companies for preclinical testing is boosting market growth.

However, the Patient Derived Xenograft Model market also faces some challenges. One of the key restraints is the high cost associated with creating and maintaining PDX models. The complexity of these models, including genetic heterogeneity and the need for specialized infrastructure and expertise, adds to the overall expenses.

Nevertheless, the market presents several attractive opportunities for key players. Advancements in technology, such as genome editing tools and humanized mouse models, enhance the utility and translatability of PDX models. Moreover, collaborations between pharmaceutical companies, academic research institutions, and contract research organizations are likely to further accelerate the adoption and availability of PDX models.

Key Features of the Study:

This study on the Patient Derived Xenograft Model market encompasses various essential features, providing comprehensive insights into the market landscape:

  • Market Size and Growth: The report offers an in-depth analysis of the global Patient Derived Xenograft Model market, including market size (in US$ Million) and compound annual growth rate (CAGR%) for the forecast period of 2023-2030, with 2022 as the base year.
  • Revenue Opportunities: It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices, aiding stakeholders in identifying lucrative opportunities.
  • Market Drivers, Restraints, and Opportunities: The study provides key insights into market drivers, restraints, and opportunities, shedding light on factors influencing market growth. It also highlights new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Company Profiles: Key players in the global Patient Derived Xenograft Model market are profiled based on parameters such as company highlights, product portfolio, key achievements, financial performance, and strategies. The list of companies covered in this study includes THE JACKSON LABORATORY, Champions Oncology, Inc, Charles River Laboratories, Crown Bioscience, Hera Biolabs, Horizon Discovery Ltd., Oncodesign, Pharmatest Services, Shanghai LIDE Biotech, Aragen Life Sciences Ltd., Creative Animodel, Urosphere, Applied StemCell and WuXi AppTec.
  • Decision-Making Insights: The report equips marketers and management authorities with valuable insights to make informed decisions regarding product launches, type up-gradation, market expansion, and marketing tactics.
  • Stakeholder Benefits: The global Patient Derived Xenograft Model market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. It provides ease in decision-making through various strategy matrices utilized in analyzing the market.

Patient Derived Xenograft Model Market Segmentation:

  • By Model Type
    • Tumor explant models
    • Cell line derived models
    • Patient derived organoids
    • Genetically engineered models
    • Others (Primary cell derived models, cell processed models etc.)
  • By Implantation Method
    • Subcutaneous Implantation
    • Orthopedic Implantation
    • Others
  • By Tumor Type
    • Gastrointestinal Tumor Model
    • Gynecological Tumor Model
    • Respiratory Tumor Model
    • Other Tumor Model
  • By End User
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Academic & Research Institutions
    • Others
  • By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Patient Derived Xenograft Model Market:
    • THE JACKSON LABORATORY
    • Champions Oncology, Inc
    • Charles River Laboratories
    • Crown Bioscience
    • Hera Biolabs
    • Horizon Discovery Ltd.
    • Oncodesign
    • Pharmatest Services
    • Shanghai LIDE Biotech
    • Aragen Life Sciences Ltd.
    • Creative Animodel
    • Urosphere
    • Applied StemCell
    • WuXi AppTec

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Patient Derived Xenograft Model, By Model Type
    • Market Patient Derived Xenograft Model, By Implantation Method
    • Market Patient Derived Xenograft Model, By Tumor Type
    • Market Patient Derived Xenograft Model, By End User
    • Market Patient Derived Xenograft Model, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Cancer Research
    • Restraints
  • Limitations of PDX Models
    • Opportunities
  • Applications in Immunotherapy Testing
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Patient Derived Xenograft Model Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Patient Derived Xenograft Model Market , By Model Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Tumor explant models
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Cell line derived models
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Patient derived organoids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Genetically engineered models
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others (Primary cell derived models, cell processed models etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Patient Derived Xenograft Model Market , By Model Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Subcutaneous Implantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Orthopedic Implantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Patient Derived Xenograft Model Market , By Tumor Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018- 2030
  • Gastrointestinal Tumor Model
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Gynecological Tumor Model
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Respiratory Tumor Model
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Other Tumor Model
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Patient Derived Xenograft Model Market , By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018- 2030
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Academic & Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

9. Patient Derived Xenograft Model Market , By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • THE JACKSON LABORATORY
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Champions Oncology, Inc
  • Charles River Laboratories
  • Crown Bioscience
  • Hera Biolabs
  • Horizon Discovery Group
  • Oncodesign
  • Pharmatest Services
  • Shanghai LIDE Biotech
  • Aragen Life Sciences Ltd.
  • Creative Animodel
  • Urosphere
  • Applied StemCell
  • WuXi AppTec
  • Analyst Views

11. Section

  • Research Methodology
  • About us